Next Article in Journal
Epigallocatechin-3-Gallate Induces Apoptosis as a TRAIL Sensitizer via Activation of Caspase 8 and Death Receptor 5 in Human Colon Cancer Cells
Previous Article in Journal
Human Clinical Relevance of the Porcine Model of Pseudoallergic Infusion Reactions
Open AccessArticle

Fecal Recovery of Probiotics Administered as a Multi-Strain Formulation during Antibiotic Treatment

DuPont Nutrition and Biosciences, Sokeritehtaantie 20, 02460 Kantvik, Finland
*
Author to whom correspondence should be addressed.
Biomedicines 2020, 8(4), 83; https://doi.org/10.3390/biomedicines8040083
Received: 10 March 2020 / Revised: 23 March 2020 / Accepted: 7 April 2020 / Published: 9 April 2020
(This article belongs to the Section Therapeutic Strategies in Different Diseases)
The present study aimed to investigate whether probiotic recovery is affected when consumed together with antibiotics. Fecal samples were collected from an earlier antibiotic associated diarrhea, randomized, placebo-controlled study with a product consisting of a combination of Lactobacillus acidophilus NCFM, Lactobacillus paracasei Lpc-37, and Bifidobacterium lactis Bi-07, B. lactis Bl-04 at equal numbers and at a total dose of 1010 CFU. Fecal samples were collected during the screening visit (T0), i.e., at the time of antibiotic prescription, and then on the last day of the antibiotic treatment (T1) as well as seven days after the subject had stopped taking the antibiotic treatment (T2) and at two weeks after completing antibiotic treatment and one week after probiotic/placebo consumption stopped (T3). Samples were analyzed for the presence of the four administered strains. The study was registered at clinicaltrials.gov as NCT01596829. Detection levels of all four strains were significantly increased from T0 to T1 and returned to baseline level from T2 to T3. There were also significantly more subjects with detectable levels of L. paracasei Lpc-37, B. lactis Bi-07, and B. lactis Bl-04 at T1 and T2 compared to T0 and T3, and compared to placebo. Each of the four strains could be detected in the feces of patients apparently unaffected by the simultaneous consumption of antibiotics. View Full-Text
Keywords: probiotic; Lactobacillus paracasei; Lactobacillus acidophilus; Bifidobacterium lactis; AAD; Antibiotic associated diarrhea; Fecal recovery probiotic; Lactobacillus paracasei; Lactobacillus acidophilus; Bifidobacterium lactis; AAD; Antibiotic associated diarrhea; Fecal recovery
Show Figures

Figure 1

MDPI and ACS Style

Forssten, S.D.; Yeung, N.; Ouwehand, A.C. Fecal Recovery of Probiotics Administered as a Multi-Strain Formulation during Antibiotic Treatment. Biomedicines 2020, 8, 83.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop